This study examined whether mesenchymal stem cells (MSCs), which are stem cells originated from embryonic mesoderm, are able to differentiate into functional hepatocyte-like cells in vitro. MSCs were isolated from human bone marrow and umbilical cord blood, and the surface phenotype and the mesoderm
Aging of mesenchymal stem cell in vitro
β Scribed by Mohyeddin Mandana Bonab; Kamran Alimoghaddam; Fatemeh Talebian; Syed Hamid Ghaffari; Ardeshir Ghavamzadeh; Behrouz Nikbin
- Publisher
- BioMed Central
- Year
- 2006
- Tongue
- English
- Weight
- 390 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1471-2121
No coin nor oath required. For personal study only.
β¦ Synopsis
Background
A hot new topic in medical treatment is the use of mesenchymal stem cells (MSC) in therapy. The low frequency of this subpopulation of stem cells in bone marrow (BM) necessitates their in vitro expansion prior to clinical use. We evaluated the effect of long term culture on the senescence of these cells.
Results
The mean long term culture was 118 days and the mean passage number was 9. The average number of PD decreased from 7.7 to 1.2 in the 10th passage. The mean telomere length decreased from 9.19 Kbp to 8.7 kbp in the 9th passage. Differentiation potential dropped from the 6th passage on. The culture's morphological abnormalities were typical of the Hayflick model of cellular aging.
Conclusion
We believe that MSC enter senescence almost undetectably from the moment of in vitro culturing. Simultaneously these cells are losing their stem cell characteristics. Therefore, it is much better to consider them for cell and gene therapy early on.
π SIMILAR VOLUMES
## Abstract Dexamethasone/ascorbic acid/glycerolphosphate (DAG) and bone morphogenic protein (BMP)β2 are potent agents in cell proliferation and differentiation pathways. This study investigates the in vitro interactions between dexamethasone and BMPβ2 for an osteoblastic differentiation of mesench
## Abstract ## Objective Osteoarthritis is characterized by an imbalance in cartilage homeostasis, which could potentially be corrected by mesenchymal stem cell (MSC)βbased therapies. However, in vivo implantation of undifferentiated MSCs has led to unexpected results. This study was undertaken to